Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LLL12B (Univ. of Maryland)
- Development stage
- Preclinical
- Lead developer
- University of Maryland College Park
- Modality
- Small Molecules
01
Overview
LLL12B (Univ. of Maryland): sourced facts only. name: "This study explored the combination of Olaparib and a novel orally bioavailable small-molecule STAT3 inhibitor, LLL12B, in human and murine TNBC cell lines." [DOI:10.1158/1538-7445.am2025-5724]; target: "This study explored the combination of Olaparib and a novel orally bioavailable small-molecule STAT3 inhibitor, LLL12B, in human and murine TNBC cell lines." [DOI:10.1158/1538-7445.am2025-5724]; developer: "University of Maryland, Baltimore, Baltimore, MD." [DOI:10.1158/1538-7445.am2025-5724]; modality: "This study explored the combination of Olaparib and a novel orally bioavailable small-molecule STAT3 inhibitor, LLL12B, in human and murine TNBC cell lines." [DOI:10.1158/1538-7445.am2025-5724]; stage: "Both Olaparib and LLL12B independently reduced cell viability, migration, and invasion, but their combination demonstrated significantly greater efficacy than either treatment alone." [DOI:10.1158/1538-7445.am2025-5724]
02
Targets
STAT3 (Signal Transducer and Activator of Transcription 3)
Beyond the preview
Go deeper on LLL12B (Univ. of Maryland).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LLL12B (Univ. of Maryland).